Skip to main content
. 2021 May 29;12(6):558. doi: 10.1038/s41419-021-03828-z

Fig. 1. MDM4 decreases ovarian cancer nodules dissemination and improves EOC patients’ overall survival probability.

Fig. 1

a Number of nodules in peritoneal organs of Empty Vector or MDM4-SK-OV-3-injected mice (n = 6, two-tailed Student’s t test, p = 0.018). b Number of peritoneum membranes nodules as in c (n = 6, two-tailed Student’s t test, p = 0.0016). c Total number of nodules present in both peritoneal organs and peritoneum membranes (n = 6, two-tailed Student’s t test, p = 0.0016). d Percentage of mice showing ascites at the final time point (n = 6, χ2 test, p < 0.0001). e Total number of nodules in Empty Vector or Mdm4-ID8 cells (n = 6 for Empty Vector, n = 7 for Mdm4, two-tailed Student’s t test, p = 0.0042). Nodules were counted blindly by two independent observers. f ID8 ascites analysis as in d (n = 15, χ2 test p < 0.0001). g OS in mice injected with Empty Vector or MDM4-SK-OV-3 cells (n = 5, log-rank test, p < 0.001). h Correlation of MDM4 expression with OS in 1656 patients with epithelial ovarian cancer followed for 15 years (log-rank test, p = 0.0004).